[HTML][HTML] Signal pathways of melanoma and targeted therapy

W Guo, H Wang, C Li - Signal transduction and targeted therapy, 2021 - nature.com
Melanoma is the most lethal skin cancer that originates from the malignant transformation of
melanocytes. Although melanoma has long been regarded as a cancerous malignancy with …

RAS-targeted therapies: is the undruggable drugged?

AR Moore, SC Rosenberg, F McCormick… - Nature reviews Drug …, 2020 - nature.com
Abstract RAS (KRAS, NRAS and HRAS) is the most frequently mutated gene family in
cancers, and, consequently, investigators have sought an effective RAS inhibitor for more …

[HTML][HTML] Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity

S Lee, J Rauch, W Kolch - International journal of molecular sciences, 2020 - mdpi.com
Mitogen-activated protein kinase (MAPK) pathways represent ubiquitous signal transduction
pathways that regulate all aspects of life and are frequently altered in disease. Here, we …

[PDF][PDF] Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress

J Tsoi, L Robert, K Paraiso, C Galvan, KM Sheu, J Lay… - Cancer cell, 2018 - cell.com
Malignant transformation can result in melanoma cells that resemble different stages of their
embryonic development. Our gene expression analysis of human melanoma cell lines and …

[HTML][HTML] Cutaneous melanoma: From pathogenesis to therapy

GC Leonardi, L Falzone, R Salemi… - International …, 2018 - spandidos-publications.com
In less than 10 years, melanoma treatment has been revolutionized with the approval of
tyrosine kinase inhibitors and immune checkpoint inhibitors, which have been shown to …

Clinical cancer genomic profiling

D Chakravarty, DB Solit - Nature Reviews Genetics, 2021 - nature.com
Technological innovation and rapid reduction in sequencing costs have enabled the
genomic profiling of hundreds of cancer-associated genes as a component of routine cancer …

Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma

BA Walker, K Mavrommatis, CP Wardell… - Blood, The Journal …, 2018 - ashpublications.org
Understanding the profile of oncogene and tumor suppressor gene mutations with their
interactions and impact on the prognosis of multiple myeloma (MM) can improve the …

[HTML][HTML] Genomic classification of cutaneous melanoma

R Akbani, KC Akdemir, B áArman Aksoy, M Albert… - Cell, 2015 - cell.com
We describe the landscape of genomic alterations in cutaneous melanomas through DNA,
RNA, and protein-based analysis of 333 primary and/or metastatic melanomas from 331 …

High-throughput functional genomics using CRISPR–Cas9

O Shalem, NE Sanjana, F Zhang - Nature Reviews Genetics, 2015 - nature.com
Forward genetic screens are powerful tools for the discovery and functional annotation of
genetic elements. Recently, the RNA-guided CRISPR (clustered regularly interspaced short …

Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

JG Doench, N Fusi, M Sullender, M Hegde… - Nature …, 2016 - nature.com
CRISPR-Cas9–based genetic screens are a powerful new tool in biology. By simply altering
the sequence of the single-guide RNA (sgRNA), one can reprogram Cas9 to target different …